Home Drug Tariff News
NCSO/Price concessions February 2012 (updated)
February 2012 NCSO and Price concessions.
The NCSO Concession has been granted for the month of February 2012 for the following products:
Betahistine 8mg tablets
Betahistine 16mg tablets
It is essential that contractors endorse the prescription fully with the letters ‘NCSO' and full details of the product dispensed (e.g. manufacturer or supplier or brand name and pack size. If a particular supplier's product is not listed with a price on the NHS RxS pricing system, pharmacies must also endorse the price paid (before discount and ex VAT)). The endorsement must also be signed or initialed and dated. If any of this information is missing, payment will be based on the Drug Tariff price rather than the endorsed product.
The following products have been granted price concessions for the month of February 2012:(These prices will automatically be applied to prescriptions submitted in February's bundle.)
Ketoprofen gel 2.5%: 100g £6.84
Nitrazepam 5mg tablets: (28 tabs) £3.98
Tolbutamide 500mg tablets: (28 tabs) £23.98
Tranexamic Acid 500mg tablets (60) £6.57 (NEW)
The NCSO and price concessions only last for the month granted. If at the beginning of the following month the situation is not resolved, a new application is made.
Please note, PSNC cannot provide details of generic products that are suspected of being affected by generic supply problems unless and until the Department of Health grants a concession. Updates will be posted on the PSNC Website. Updates will also be sent out via our e-news email list so by subscribing to this email list, you can receive an email as soon as any announcements are made
If you have problems obtaining a Part VIII product or problems obtaining the product at the set Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC Website. If you have been able to source the product, please provide full details of the supplier and price paid. PSNC will investigate the extent of the problem and if appropriate discuss the issue with the Department of Health.
Posted 20 February 2012